The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.

Antonios Antoniou , C. Michael Steel , J. G.M. Klijn , Christine Lasset
Clinical Cancer Research 6 ( 3) 782 -789

199
2000
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.

Caryn Lerman , Margaret A. Tucker , Ronald G. Kase , Therese R. Giambarresi
Cancer Epidemiology, Biomarkers & Prevention 4 ( 2) 169 -173

195
1995
Papillary Thyroid Cancer and Polymorphic Variants in TSHR- and RET-Related Genes: a Nested Case-Control Study within a Cohort of U.S. Radiologic Technologists

Stefan Lönn , Parveen Bhatti , Bruce H. Alexander , Marbin A. Pineda
Cancer Epidemiology, Biomarkers & Prevention 16 ( 1) 174 -177

28
2007
Breast Cancer Risk Polymorphisms and Interaction with Ionizing Radiation among U.S. Radiologic Technologists

Parveen Bhatti , Michele M. Doody , Bruce H. Alexander , Jeff Yuenger
Cancer Epidemiology, Biomarkers & Prevention 17 ( 8) 2007 -2011

25
2008
Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis.

Mark E. Sherman , Jennifer S. Lee , R. Tucker Burks , Jeffery P. Struewing
International Journal of Gynecological Pathology 18 ( 2) 151 -157

44
1999
Candidate Single Nucleotide Polymorphism Selection using Publicly Available Tools: A Guide for Epidemiologists

Parveen Bhatti , Deanna M. Church , Joni L. Rutter , Jeffery P. Struewing
American Journal of Epidemiology 164 ( 8) 794 -804

33
2006
CHEK2:1100delC and female breast cancer in the United States.

Lut�cia H. Mateus Pereira , Alice J. Sigurdson , Michele M. Doody , Marbin A. Pineda
International Journal of Cancer 112 ( 3) 541 -543

21
2004
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.

Patricia Hartge , Nilanjan Chatterjee , Sholom Wacholder , Lawrence C. Brody
Epidemiology 13 ( 3) 255 -261

34
2002
Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up of BRCA1 Mutation Carriers

Joan L. Kramer , Isela A. Velazquez , Bingshu E. Chen , Philip S. Rosenberg
Journal of Clinical Oncology 23 ( 34) 8629 -8635

126
2005
Use of next-generation sequencing tests to guide cancer treatment: Results From a Nationally Representative Survey of Oncologists in the United States.

Andrew N. Freedman , Carrie N. Klabunde , Kristine Wiant , Lindsey Enewold
JCO Precision Oncology 2 ( 2) 1 -13

24
2018
Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.

Alice J. Sigurdson , Charles E. Land , Parveen Bhatti , Marbin Pineda
Radiation Research 171 ( 1) 77 -88

33
2009
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.

Larissa A. Korde , Christine M. Mueller , Jennifer T. Loud , Jeffery P. Struewing
Breast Cancer Research and Treatment 125 ( 1) 169 -173

21
2011
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists.

Alice J. Sigurdson , Parveen Bhatti , Shih-chen Chang , Preetha Rajaraman
Breast Cancer Research and Treatment 118 ( 1) 177 -184

16
2009
Germline p16 mutations in familial melanoma.

Christopher J. Hussussian , Jeffery P. Struewing , Alisa M. Goldstein , Paul A. T. Higgins
Nature Genetics 8 ( 1) 15 -21

1,576
1994
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

Jeffery P. Struewing , Dvorah Abeliovich , Tamar Peretz , Naaman Avishai
Nature Genetics 11 ( 2) 198 -200

807
1995
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1

Carole Oddoux , Jeffery P. Struewing , C. Mark Clayton , Susan Neuhausen
Nature Genetics 14 ( 2) 188 -190

341
1996
Seroprevalence of hepatitis A, B, and C in a United States military recruit population.

Kenneth C. Hyams , Jeffery P. Struewing , Gregory C. Gray
Military Medicine 157 ( 11) 579 -582

18
1992
The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.

Denise L. Stredrick , Montserrat Garcia-Closas , Marbin A. Pineda , Parveen Bhatti
Human Mutation 27 ( 6) 538 -544

54
2006
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.

Joni L. Rutter , Christina M. Bromley , Alisa M. Goldstein , David E. Elder
Cancer 101 ( 12) 2809 -2816

27
2004